A Case of Euthyroid Graves’ Ophthalmopathy in a Patient Sero-Negative for TSH Receptor Autoantibody

Figure 2

Clinical course of the patient. The patient was hospitalized and received intravenous and oral corticosteroid therapy in conjunction with orbital radiotherapy. Intravenous methylprednisolone 1000mg/day for 3 days followed by oral prednisolone 30mg/day for 4 days were defined as one cycle, and he received 3 cycles consecutively with a slightly decreased methylprednisolone i.v. in the third cycle. Orbital radiation therapy was commenced on day 2 and 2Gy/day radiation was continued for 10 days (20Gy total). The patient was discharged on oral corticosteroid therapy with decreasing doses.